Norina Passerini

Title: Norina Passerini: Innovator in Pharmaceutical Chemistry

Introduction

Norina Passerini is a distinguished inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of four patents to her name, Passerini's work focuses on innovative solutions for mental health treatments.

Latest Patents

Among her latest patents, Passerini has developed N-tricyclic derivatives of azetidine, which are disclosed in two separate patents. The first patent presents novel compounds of the general formula where A is a C1-C3 alkylene group, a C2-C3 alkenylene group, or a cyclopropylene group. These compounds exhibit anti-depressant, anti-convulsant, and anxiolytic activities. An illustrative compound from this patent is 1-[5-(10, 11-dihydro-5H-dibenzo [a,d]cyclopheptenyl)]-3-methyl-amino-azetidine. The second patent also focuses on N-tricyclic derivatives of azetidine, where A is defined as a --CH2--S-- or --S--CH2-- group. An example from this patent is 1-[11-(6,11-dihydro-dibenzo [b,e] thiopinyl)]-3-methylamino-azetidine, which shares similar therapeutic benefits.

Career Highlights

Passerini is currently employed at Carlo Erba S.p.a., a prominent company in the pharmaceutical industry. Her work at Carlo Erba S.p.a. has allowed her to further her research and development efforts in creating effective pharmaceutical compounds.

Collaborations

Throughout her career, Passerini has collaborated with notable colleagues, including Piero Melloni and Arturo Della Torre. These collaborations have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Norina Passerini is a remarkable inventor whose work in pharmaceutical chemistry has the potential to impact mental health treatment significantly. Her innovative patents and collaborations highlight her dedication to advancing medical science.